Mehmet Dadaci

Mehmet Dadaci

Auto-generated profile, based on publicly available information

Mehmet Dadaci

Necmettin Erbakan University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2015 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
MDMehmet Dadaci
Mehmet Dadaci
ZAZeynep Altuntas
Zeynep Altuntas
BIBilsev Ince
Bilsev Ince
FBFatma Bilgen
Fatma Bilgen
OTOsman Tufekci
Osman Tufekci
NPNecdet Poyraz
Necdet Poyraz
Nicolau syndrome is a rare complication of intramuscular injection that leads to local ischemic necrosis of the skin and adipose tissue. In this paper, we discuss etiologies, risk factors, and treatment options for gluteal Nicolau syndrome referring to patients treated in our hospital. Our study includes 17 women who visited our clinic with symptoms of gluteal necrosis secondary to intramuscular injection. The following variables were taken into account: injection site, drug administered, frequency of injections, the person who administered the injections, needle size, and needle tip color. Magnetic resonance images obtained in the aftermath of intramuscular injection application were carefully analyzed for presence of necrosis, cyst formation and the thickness of the gluteal fat tissue layer. Drugs that had been received in intramuscular injection were exclusively non-steroidal anti-inflammatory drugs. Mean patient BMI was 41.8 (all patients were considered as obese), and mean gluteal fat thickness was 54 mm. Standard length of needles (3.8 cm) had been used in procedures. The wounds were treated with primary closure in 11 patients and with local flap therapy in 6 patients. The observed necrosis was a consequence of misplaced gluteal injection, where drugs were injected into the adipose tissue instead of the muscle due to the extreme thickness of the fat layer, on one hand, and the inappropriate length of standard needles, on the other hand. Intramuscular injection should be avoided in obese patients whenever possible: if it is necessary, proper injection technique should be used.

28 June 2019 in Discover Oncology
Verified
Journal Article
Open access
PDF file
BIBilsev Ince
Bilsev Ince
MYMehmet Emin Cem Yildirim
Mehmet Emin Cem Yildirim
MDMehmet Dadaci
Mehmet Dadaci
The study aimed to determine whether 25-OH vitamin D3 deficiency is present in patients with diagnosed BCC, and the effect of vitamin D replacement on the rates of BCC recurrence in patients with 25-OH vitamin D3 deficiency. In this prospective study, between 2012 and 2017, in the first stage, 25-OH vitamin D3 levels of all patients diagnosed with BCC between 2012 and 2013 were evaluated. In the second stage between 2014 and 2015, we evaluated the 25-OH vitamin D3 level of patients who had 25-OH vitamin D3 level < 25 ng/mL. All the patients included in the second stage had BCC recurrence. In the third stage, the patients who were diagnosed 25-OH vitamin D3 deficiency with BCC, between 2015 and 2017, were studied. The mean 25-OH vitamin D3 level of the patients in the second stage was 10.12 ng/mL. Recurrence was observed in 9.64% of the patients in the second stage. The mean level of serum 25-OH vitamin D3 in the third stage was 40.1 ng/mL, and 3.49% of these patients presented with recurrence. In all the patients as the initial diagnosis and following the 25-OH vitamin D3 level in all the patients with BCC recurrence, maintaining 25-OH vitamin D3 levels above 25 ng/mL can significantly reduce the recurrence rate.

16 January 2016 in Microsurgery
Verified
Journal Article
Closed access
PDF file
BIBilsev Ince
Bilsev Ince
AAAbdullah Arslan
Abdullah Arslan
MDMehmet Dadaci
Mehmet Dadaci
DODoç.Dr. Pembe OLTULU
Doç.Dr. Pembe OLTULU
FBFatma Bilgen
Fatma Bilgen

1 April 2016 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
ZKZeynep Karacor-Altuntas
Zeynep Karacor-Altuntas
MDMehmet Dadaci
Mehmet Dadaci
BIBilsev Ince
Bilsev Ince
MKMehtap Karamese
Mehtap Karamese
NSNedim Savaci
Nedim Savaci
Various pedicle techniques have been described in breast reduction surgery. However, in cases of massive hypertrophy, the free nipple graft technique is still being performed by some surgeons out of fear of losing the nipple-areolar complex (NAC). As such, we evaluated patients with severe gigantomastia who underwent the central pedicle horizontal scar reduction mammaplasty technique. The records of 257 patients who underwent the central pedicle reduction technique were retrospectively reviewed. The demographic properties of the patients and the distances from the midclavicular point to the nipple were recorded. Patients whose distance from the midclavicular point to both nipple areolar complexes (NACs) was 38 cm or greater were included in this study. Resection weights and postoperative complications were evaluated. The distance from the midclavicular point to both NACs was 38 cm or greater in 53 patients (106 breasts). The age range of the patients was 17 to 73 years, and the mean body mass index was 39.6 kg/m. The range of distances from the midclavicular point to the nipple was 38 to 52 cm. The weight of the breast tissue excised ranged between 1450 and 2785 g. None of the patients experienced total nipple loss postoperatively, and all of the patients were satisfied with the aesthetic results. We were able to reduce all of the breasts safely, without using the free nipple grafting technique, even in very large breasts. This study shows that the central pedicle horizontal scar reduction technique is a very safe and effective method for use in massive reductions. Therefore, we strongly recommend using the central pedicle reduction mammaplasty technique in cases of gigantomastia.

1 August 2016 in Indian Journal of Orthopaedics
Verified
Journal Article
Open access
MDMehmet Dadaci
Mehmet Dadaci
BIBilsev Ince
Bilsev Ince
ZAZeynep Altuntas
Zeynep Altuntas
OBOzan Bitik
Ozan Bitik
HKHaldun Onuralp Kamburoglu
Haldun Onuralp Kamburoglu
HUHakan Uzun
Hakan Uzun
The domain name Ijoonline.com is for sale. Call BuyDomains at 844-896-7299 to get a price quote and get your business online today!

1 January 2016 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
MDMehmet Dadaci
Mehmet Dadaci
NKNimet Karagülle
Nimet Karagülle
ESErhan Sönmez
Erhan Sönmez
ZDZeynep Dadaci
Zeynep Dadaci
EIEvren Tevfik İşci̇
Evren Tevfik İşci̇
AEAli Yücel Erk
Ali Yücel Erk
Background/aim: The aim of this study was to compare electrospun caprolactone (EC) and poly(lactic acid-epsilon-caprolactone) (PLCL) nerve conduits with nerve graft in a rat sciatic nerve defect model. Materials and methods: A total of 32 male Wistar albino rats were divided into 4 groups, with 8 rats in each group. A nerve defect of 1 cm was constructed in the left sciatic nerve of the rats. These defects were left denuded in the sham group, and reconstructed with nerve grafts, PLCL, and EC nerve conduits in the other groups. After 3 months, nerve regenerations were evaluated macroscopically, microscopically, and electrophysiologically. The numbers of myelinated axons in the cross-sections of the nerves were compared between the groups. Results: Macroscopically, all nerve coaptations were intact and biodegradation was detected in nerve conduits. Electromyographic assessment and count of myelinated axons in the cross-sections of the nerves displayed the best regeneration in the nerve graft group (P < 0.001) and similar results were obtained in the PLCL and EC nerve conduit groups (P = 0.79). Light and electron microscopy studies demonstrated nerve regeneration in both nerve conduit groups. Conclusion: EC nerve conduits and PLCL nerve conduits yielded similar results and may be alternatives to nerve grafts as they biodegrade.